AngioDynamics | ANGO - Cash And Equivalent


AngioDynamics reported $41.64M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Accuray USD 41.29M 22.05M Dec/2025
AngioDynamics USD 41.64M 14.26M Sep/2025
Artivion USD 55.76M 9.14M Mar/2026
AtriCure USD 146.16M 21.26M Mar/2026
Boston Scientific USD 1.45B 512M Mar/2026
Edwards Lifesciences USD 2.4B 538M Mar/2026
ICU Medical USD 307.96M 8.23M Dec/2025
Inogen USD 106.48M 2.79M Sep/2025
J&J USD 21.69B 1.98B Mar/2026
Medtronic USD 1.15B 135M Dec/2025
Merit Medical Systems USD 488.08M 41.68M Mar/2026
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Orthofix International USD 120.28M 38.25M Mar/2026
Smiths GBP 345M 47M Dec/2025
Tandem Diabetes Care USD 179.32M 88.69M Mar/2026
Teleflex USD 309.41M 69.15M Mar/2026
Terumo JPY 217.16B 12.86B Sep/2025
Trinity Biotech USD 1.34M 3.83M Sep/2025